Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Nasdaq  >  ANTA PHAR    

 SummaryNewsCalendarCompanyFinancialsConsensusRevisions 
Financials ($)
Sales 2015 0,33 M
EBIT 2015 -35,8 M
Net income 2015 -34,9 M
Debt 2015 -
Yield 2015 -
Sales 2016 3,67 M
EBIT 2016 -49,6 M
Net income 2016 -45,9 M
Debt 2016 -
Yield 2016 -
PER 2015 -
PER 2016
Capi. / Sales 2015 1 305x
Capi. / Sales 2016 119x
Capitalization 435 M
More Financials
Company
Anthera Pharmaceuticals, Inc. is a biopharmaceutical company, which is focused on developing and commercializing products to treat treat serious and life-threatening diseases, including lupus, lupus with glomerulonephritis, IgA nephropathy, and exocrine pancreatic insufficiency due to cystic... 
Sector
Pharmaceuticals
Calendar
11/03Earnings Release
More about the company
Latest news on ANTA PHAR
07/15 ANTHERA PHARMACEUTICALS : Announces Completion of Public Offering of Common Stoc..
07/14 Anthera Pharmaceuticals Announces Completion of Public Offering of Common Sto..
07/13 ANTHERA PHARMACEUTICALS : Entry into a Material Definitive Agreement, Other Even..
07/10 ANTHERA PHARMACEUTICALS : Announces Pricing of Public Offering of Common Stock
07/09 Anthera Pharmaceuticals Announces Pricing of Public Offering of Common Stock
07/09 ANTHERA PHARMACEUTICALS : Announces Proposed Public Offering of Common Stock
07/08 Anthera Pharmaceuticals Announces Proposed Public Offering of Common Stock
06/26 Anthera Pharmaceuticals Added to the Russell 2000(R) and Russell 3000(R) Inde..
More news
Sector news : Biopharmaceuticals
07:01p BRISTOL MYERS SQUIBB : Kyowa Hakko Kirin and Bristol-Myers Squibb Announce Immun..
05:06pDJVERTEX PHARMACEUTICALS : Revenue Rises 20%
04:38p FOUNDATION MEDICINE : reports 2Q loss
More sector news : Biopharmaceuticals
Comments 
Advertisement
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions